Chlorpromazine inhibits concanavalin A-induced liver injury independently of cytokine modulation
- 1 March 1997
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 55 (3) , 127-131
- https://doi.org/10.1016/s0165-2478(97)02700-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitopeJournal of Hepatology, 1995
- T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.The Journal of Experimental Medicine, 1994
- Ca 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen 1The FASEB Journal, 1993
- A T cell-dependent experimental liver injury in mice inducible by concanavalin A.Journal of Clinical Investigation, 1992
- Effects of anti-oxidants on ornithine decar☐ylase in mitogenically-activated T lymphocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Dissociation of immunosuppression by chlorpromazine and trifluoperazine from pharmacologic activities as dopamine antagonistsInternational Journal of Immunopharmacology, 1991
- Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock.The Journal of Experimental Medicine, 1991
- Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte inductionCellular Immunology, 1987
- Induction of ornithine decarboxylase in mouse tissues following the injection of mitogenic substancesBiochemical Pharmacology, 1984
- Purification of ornithine decarboxylase from kidneys of androgen-treated miceBiochemistry, 1982